Peer-reviewed veterinary case report
Complications and outcomes of laparoscopic spleen removal in dogs
By McGaffey, Marissa E S et al.·Published in Journal of the American Veterinary Medical Association·2022·Ontario Veterinary College, Canada·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Complications and outcomes associated with laparoscopic-assisted splenectomy in dogs.
- Species:
- dog
Plain-English summary
A group of 136 dogs underwent a minimally invasive surgery called laparoscopic-assisted splenectomy (LAS) to remove splenic masses or treat splenic diseases. Most of the dogs had splenic masses, and the surgery took about 47 minutes, with most dogs staying in the hospital for about 28 hours afterward. While some dogs experienced minor complications, nearly all of them recovered well, with only one dog not surviving due to a suspected blood clot. Overall, LAS showed low rates of serious complications, making it a safe option for dogs with splenic issues.
People also search for: dog splenic mass surgery · laparoscopic splenectomy for dogs · dog splenic disease treatment
Abstract
OBJECTIVE: To report the perioperative characteristics and outcomes of dogs undergoing laparoscopic-assisted splenectomy (LAS). ANIMALS: 136 client-owned dogs. PROCEDURES: Multicentric retrospective study. Medical records of dogs undergoing LAS for treatment of naturally occurring splenic disease from January 1, 2014, to July 31, 2020, were reviewed. History, signalment, physical examination and preoperative diagnostic test results, procedural information, complications, duration of hospitalization, histopathologic diagnosis, and perioperative outcomes were recorded. Perioperative complications were defined using the Veterinary Cooperative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) guidelines. RESULTS: LAS was performed for treatment of a splenic mass (124/136 [91%]), immune-mediated disease (7/136 [5%]), splenomegaly (4/136 [3%]), or immune-mediated disease in conjunction with a splenic mass (1/136 [1%]). Median splenic mass size was 1.3 cm3/kg body weight. Conversion to open laparotomy occurred in 5.9% (8/136) of dogs. Complications occurred in 78 dogs, with all being grade 2 or lower. Median surgical time was 47 minutes, and median postoperative hospital stay was 28 hours. All but 1 dog survived to discharge, the exception being postoperative death due to a suspected portal vein thrombus. CLINICAL RELEVANCE: In the dogs of this report, LAS was associated with low rates of major complications, morbidity, and mortality when performed for a variety of splenic pathologies. Minimally invasive surgeons can consider the LAS technique to perform total splenectomy in dogs without hemoabdomen and with spleens with modest-sized splenic masses up to 55.2 cm3/kg, with minimal rates of complications, morbidity, and mortality.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/35482563/